The Clorox Company (NYSE:CLX) Receives Consensus Rating of “Reduce” from Brokerages

The Clorox Company (NYSE:CLX) has earned an average recommendation of “Reduce” from the seventeen brokerages that are covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and one has issued a buy rating on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $130.20.

Several analysts have issued reports on CLX shares. Bank of America lowered their target price on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. JPMorgan Chase & Co. lowered their target price on Clorox from $135.00 to $127.00 and set a “neutral” rating on the stock in a research note on Friday, October 10th. Wells Fargo & Company lowered their target price on Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 25th. UBS Group lowered their target price on Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. Finally, The Goldman Sachs Group lowered their target price on Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research note on Wednesday, October 1st.

Clorox Stock Performance

Shares of Clorox stock opened at $115.21 on Wednesday. The business’s fifty day simple moving average is $120.99 and its 200 day simple moving average is $126.50. The firm has a market capitalization of $14.03 billion, a P/E ratio of 17.67, a price-to-earnings-growth ratio of 0.96 and a beta of 0.52. Clorox has a 12 month low of $114.55 and a 12 month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business’s revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts anticipate that Clorox will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a $1.24 dividend. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.3%. Clorox’s payout ratio is 76.07%.

Insider Buying and Selling at Clorox

In other news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.63% of the company’s stock.

Hedge Funds Weigh In On Clorox

Hedge funds have recently made changes to their positions in the stock. Total Investment Management Inc. bought a new position in Clorox in the 2nd quarter worth about $25,000. American National Bank & Trust increased its stake in Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after acquiring an additional 89 shares during the last quarter. NewSquare Capital LLC increased its stake in Clorox by 567.6% in the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after acquiring an additional 193 shares during the last quarter. True Wealth Design LLC increased its stake in Clorox by 1,020.0% in the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock worth $28,000 after acquiring an additional 204 shares during the last quarter. Finally, Darwin Wealth Management LLC bought a new position in Clorox in the 2nd quarter worth about $29,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.